Gomes Inês Afonso, Soares Patricia, Rocha João Victor, Gama Ana, Laires Pedro Almeida, Moniz Marta, Pedro Ana Rita, Dias Sónia, Goes Ana Rita, Leite Andreia, Nunes Carla
Comprehensive Health Research Center, Universidade NOVA de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal.
NOVA National School of Public Health, Public Health Research Center, Universidade NOVA de Lisboa, Av. Padre Cruz, 1600-560 Lisboa, Portugal.
Vaccines (Basel). 2022 Feb 12;10(2):281. doi: 10.3390/vaccines10020281.
An online cross-sectional study on COVID-19 vaccination adhesion was conducted in Portugal nine months after vaccination rollout (September-November 2021). Logistic regression was used to identify factors associated with hesitancy to take the COVID-19 vaccine in the community-based survey, "COVID-19 Barometer: Social Opinion". Hesitancy was 11%; however, of those, 60.5% stated that they intended to take the vaccine. Hesitancy was associated with factors such as lower monthly household income; no intention of taking the flu vaccine this year; perceived reasonable health status; having two or more diseases; low confidence in the health service response; worse perception of the adequacy of anti-COVID-19 government measures; low or no perceived risk of getting COVID-19; feeling agitated, anxious or sad some days; and lack of trust in the safety and efficacy of the vaccines. Confidence in vaccines, namely against COVID-19, is paramount for public health and should be monitored during vaccination rollout. Clear communication of the risks and benefits of vaccination needs improvement to increase adherence and public confidence.
在葡萄牙疫苗接种推出九个月后(2021年9月至11月),开展了一项关于新冠疫苗接种依从性的在线横断面研究。在基于社区的 “新冠晴雨表:社会舆论” 调查中,采用逻辑回归来确定与对新冠疫苗接种犹豫不决相关的因素。犹豫不决率为11%;然而,在这些人中,60.5%表示他们打算接种疫苗。犹豫不决与以下因素相关,如家庭月收入较低;今年不打算接种流感疫苗;自认为健康状况良好;患有两种或更多疾病;对卫生服务应对措施信心不足;对政府抗新冠措施的充分性评价较差;自认为感染新冠的风险较低或没有风险;有些日子感到烦躁、焦虑或悲伤;以及对疫苗的安全性和有效性缺乏信任。对疫苗的信心,尤其是对新冠疫苗的信心,对公共卫生至关重要,在疫苗接种推出过程中应予以监测。需要改进对疫苗接种风险和益处的清晰沟通,以提高依从性和公众信心。